Analysis of SIGLEC12 expression, immunomodulation and prognostic value in renal cancer using multiomic databases
Siglecs belong to a family of immune regulatory receptors predominantly found on hematopoietic cells. They interact with Sia, resulting in the activation or inhibition of the immune response. Previous reports have suggested that the SIGLEC12 gene, which encodes the Siglec-XII protein, is expressed i...
Main Authors: | Amobichukwu K. Ogbodo, Denis Mustafov, Mohit Arora, George I. Lambrou, Maria Braoudaki, Shoib S. Siddiqui |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024003177 |
Similar Items
-
Cancer multi-omics-based differential expression analysis and prognostic potential of identified hub targets of myco-metabolites for breast carcinoma and lung carcinoma
by: Singh Shreya, et al.
Published: (2025-02-01) -
Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer
by: Quan Zhou, et al.
Published: (2022-04-01) -
Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer
by: Yujie Zhang, et al.
Published: (2020-06-01) -
The expression characteristic and prognostic role of Siglec‐15 in lung adenocarcinoma
by: Haijun Sun, et al.
Published: (2024-05-01) -
Human‐specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression
by: Shoib S Siddiqui, et al.
Published: (2021-02-01)